Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rami Levin currently holds 14,250 shares of CNS Pharmaceuticals, Inc. (CNSP), valued at approximately $0. This represents their equity stake as CEO and President.
Based on SEC Form 4 filings, Rami Levin has been a net neutral trader of CNSP stock. They have purchased $0 and sold $0 worth of shares.
Rami Levin's most recent insider trade was on Aug 14, 2026, when they sold 4,750 shares at $0.00 per share.
Rami Levin serves as CEO and President at CNS Pharmaceuticals, Inc. (CNSP). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Rami Levin holds the position of CEO and President at CNS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Rami Levin has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Rami Levin was on Aug 14, 2026, when they sold $0 worth of CNSP shares. This transaction involved 4,750 shares at N/A per share.
Rami Levin currently owns 14,250 shares of CNS Pharmaceuticals, Inc. (CNSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rami Levin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rami Levin has 2 Form 4 filings on record as an insider at CNS Pharmaceuticals, Inc..
Set alerts for Rami Levin and 40,000+ other insiders.